The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Set To Open Lower Ahead Of US Non-Farm Payrolls

Fri, 08th Nov 2013 07:48

LONDON (Alliance News) - UK equities are called to follow Asian and US stock indices lower Friday as investors await much-anticipated US jobs market data.

Stocks worldwide were dragged lower Thursday after a report from the US Commerce Department showed stronger-than-expected US third-quarter GDP growth. The report revealed that US gross domestic product rose by 2.8% in the third-quarter, from a 2.5% increase in the second-quarter, coming in ahead of economist estimates of an increase of 2.0%.

The strong figure, by dismissing signs that the US economy had slowed down through the end of the third-quarter, was seen by many as increasing the likelihood that the Federal Reserve may taper its USD85 billion-per-month asset buying programme in December.

Investor focus Friday shifts towards the health of the US jobs markets. A stronger-than-expected nonfarm payrolls report for October is likely to further increase the chance that the Fed will curb its asset-buying scheme. The data, scheduled at 1330 GMT, is expected to come in at 125,000, from 148,000 in September.

Separate US reports on personal income and spending and consumer spending, also are expected at 1330 GMT, will also provide a clearer picture on whether the US economy is resilient enough to withstand an early start to stimulus tapering.

Positive Chinese data released overnight has largely been dismissed.

China's trade surplus more than doubled in October, boosted by a stronger-than-expected rebound in exports, data from the General Administration of Customs showed Friday, suggesting that the economic recovery is gaining traction. The trade surplus jumped to USD31.1 billion in October from USD15.21 billion in September. Economists expected an increase to USD23.9 billion.

The country's exports grew 5.6% year-on-year in October compared with forecast for a 3.2% rise. For September, overseas shipments had fallen 0.3%. Imports grew 7.6% annually, faster than the 7.4% increase in the previous month, however slightly missing expectations of a rise to 8.5%.

The positive data will encourage Chinese leaders, gathering in Beijing this weekend for a key Communist Party meeting, to accelerate efforts to unlock another wave of economic reforms.

Ahead of the London open, the Nikkei trades down 1%, with the Hang Seng down 0.7%.

In the US, Wall Street closed lower Thursday. The DJIA closed down 1%, the S&P closed down 1.3%, and the Nasdaq Composite closed down 1.9%.

IG is calling the FTSE 100 to open lower at approximately 6666.0 points.

The euro is set for another volatile day Friday, having been hit Thursday on the back of the European Central Bank's rate cut and strong US third-quarter GDP growth.

Standard and Poor's has slashed France's sovereign credit ratings by one notch to 'AA', citing weak economic prospects and fiscal policy constraints.

In the wake of the decision, EURUSD and EURJPY were knocked, said CitiFX Wire's Nishtha Asthana. "The overall reaction however, is still muted," Asthana added.

However, the euro has been boosted in the aftermath of a strong German trade report. Germany's total trade surplus rose to EUR20.4 billion in September, compared to expectations for an increase of EUR15.5 billion.

Ahead of the UK equity market open, the euro trades at USD1.3410, GBP1.6101 and JPY131.632.

In Friday's data calendar, UK goods and total trade balance numbers are scheduled for 0930 GMT.

There has been a number of corporate releases ahead of the London open Friday. Blue-chip Rolls-Royce has been joined by FTSE 250-listed Hikma Pharmaceuticals, Bovis Homes and Tullett Prebon, amongst others, in releasing interim management statements. Rentokil initial has provided a trading statement. Merlin Entertainment has announced its IPO price.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.